Cargando…

TERT promoter mutations in melanoma survival

Detalles Bibliográficos
Autores principales:	Nagore, Eduardo, Rachakonda, Sivaramakrishna, Kumar, Rajiv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422178/ https://www.ncbi.nlm.nih.gov/pubmed/30899422 http://dx.doi.org/10.18632/oncotarget.26688

Ejemplares similares

TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation
por: Vallarelli, Andrelou F., et al.
Publicado: (2016)

Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example
por: Hemminki, Kari, et al.
Publicado: (2020)

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences
por: Heidenreich, Barbara, et al.
Publicado: (2015)

Variants at the 9p21 locus and melanoma risk
por: Maccioni, Livia, et al.
Publicado: (2013)

TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk
por: Osella-Abate, Simona, et al.
Publicado: (2019)

Telomere length and survival in primary cutaneous melanoma patients
por: Rachakonda, Sivaramakrishna, et al.
Publicado: (2018)

Mapping of deletion breakpoints at the CDKN2A locus in melanoma: detection of MTAP-ANRIL fusion transcripts
por: Xie, Huaping, et al.
Publicado: (2016)

Author Correction: Telomere length and survival in primary cutaneous melanoma patients
por: Rachakonda, Sivaramakrishna, et al.
Publicado: (2018)

Genetic alterations in seborrheic keratoses
por: Heidenreich, Barbara, et al.
Publicado: (2017)

ETS1, nucleolar and non-nucleolar TERT expression in nevus to melanoma progression
por: Kohli, Jaskaren S., et al.
Publicado: (2017)

TERT Promoter Mutations and Telomerase in Melanoma
por: Guo, Yuchen, et al.
Publicado: (2022)

Telomeres and Telomere Length: A General Overview
por: Srinivas, Nalini, et al.
Publicado: (2020)

RICTOR involvement in the PI3K/AKT pathway regulation in melanocytes and melanoma
por: Laugier, Florence, et al.
Publicado: (2015)

Frequent DPH3 promoter mutations in skin cancers
por: Denisova, Evgeniya, et al.
Publicado: (2015)

Germline TERT promoter mutations are rare in familial melanoma
por: Harland, Mark, et al.
Publicado: (2015)

Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma
por: Maturo, Maria Giovanna, et al.
Publicado: (2020)

TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
por: Griewank, K G, et al.
Publicado: (2013)

Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis
por: van Poppelen, Natasha M., et al.
Publicado: (2021)

TERT Promoter Revertant Mutation Inhibits Melanoma Growth through Intrinsic Apoptosis
por: Wang, Yanbing, et al.
Publicado: (2022)

TERT promoter mutations and monoallelic activation of TERT in cancer
por: Huang, F W, et al.
Publicado: (2015)

SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma
por: Willmes, Christoph, et al.
Publicado: (2016)

Somatic Mutations in Exocrine Pancreatic Tumors: Association with Patient Survival
por: Rachakonda, P. Sivaramakrishna, et al.
Publicado: (2013)

TERT Promoter Mutations Increase Sense and Antisense Transcription from the TERT Promoter
por: Hafezi, François, et al.
Publicado: (2021)

Inherited variation in the PARP1 gene and survival from melanoma
por: Davies, John R, et al.
Publicado: (2014)

TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma
por: Xie, Hong, et al.
Publicado: (2014)

The Solo Play of TERT Promoter Mutations
por: Hafezi, François, et al.
Publicado: (2020)

TERT Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma
por: Blateau, Pauline, et al.
Publicado: (2020)

TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients
por: Del Bianco, Paola, et al.
Publicado: (2020)

Mutational Characterization of Cutaneous Melanoma Supports Divergent Pathways Model for Melanoma Development
por: Millán-Esteban, David, et al.
Publicado: (2021)

Influence of Genetic Variants in Type I Interferon Genes on Melanoma Survival and Therapy
por: Lenci, Romina Elizabeth, et al.
Publicado: (2012)

Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma
por: Hugdahl, Emilia, et al.
Publicado: (2018)

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF(V600E)/TERT promoter double-mutated glioma
por: Gabler, Lisa, et al.
Publicado: (2019)

TERT promoter hotspot mutations in breast cancer
por: Shimoi, Tatsunori, et al.
Publicado: (2017)

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers
por: Stern, Josh Lewis, et al.
Publicado: (2015)

Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression
por: Salgado, Catarina, et al.
Publicado: (2020)

Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma
por: Dono, M, et al.
Publicado: (2014)

TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas
por: Gao, Ke, et al.
Publicado: (2015)

Human TERT Promoter Mutations in Atypical and Anaplastic Meningiomas
por: Mellai, Marta, et al.
Publicado: (2021)

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2021)

An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study
por: Davies, John R, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_egrcvnnrbc3sagntvs28kmaf2a